UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-Q
(MARK ONE)
[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2008

                                       OR

[ ]      TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
         ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________________ TO __________________

COMMISSION FILE NUMBER: 333-145469

                              PREMIER ENERGY CORP.
                       fka Premier Nursing Products Corp.
                       ----------------------------------
             (Exact name of registrant as specified in its charter)

            FLORIDA                                       20-8724818
            -------                                       ----------
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
of incorporation or organization)

14785 Preston Road, Suite 550, Dallas, TX                    75254
-----------------------------------------                    -----
(Address of principal executive offices)                  (Zip Code)

                                 (972) 789-5151
                                 --------------
              (Registrant's telephone number, including area code)

                26 Broadway, 22nd Floor, New York, New York 10004
                -------------------------------------------------
              (Former name, former address and former fiscal year,
                          if changed since last report)

         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No [ ]

         Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of "large accelerated filer," "accelerated filer"
and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer                 [ ]        Accelerated filer         [ ]
Non-accelerated filer                   [ ]        Smaller reporting company [X]
(Do not check if smaller reporting company)

         Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act) Yes [ ] No [X]

         Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date. 210,600,000 shares
of common stock are issued and outstanding as of January 12, 2009.

<PAGE>

                                TABLE OF CONTENTS
                                                                            Page
                                                                             No.
                                                                            ----

                         PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements

         Balance Sheets at November 30, 2008 (unaudited) and May 31, 2008 ..   4

         Statements of Operations for the three months and six months ended
         November 30, 2008 (unaudited) and 2007 (unaudited) and cumulative
         results of operations from December 26, 2006 (Date of Inception) to
         November 30, 2008 (unaudited) .....................................   5

         Statements of Changes in Stockholders' Equity (Deficiency) as of
         November 30, 2008 (unaudited) .....................................   6

         Statements of Cash Flows for the six months ended November 30, 2008
         (unaudited) and 2007 (unaudited) and cumulative results of
         operations from December 26, 2006 (Date of Inception) to November
         30, 2008 (unaudited) ..............................................   7

         Notes to Financial Statements (unaudited) .........................   8

Item 2.  Management's Discussion and Analysis of Financial Condition and
         Results of Operations. ............................................  15

Item 3.  Quantitative and Qualitative Disclosures About Market Risk. .......  16

Item 4T. Controls and Procedures. ..........................................  16

                           PART II - OTHER INFORMATION

Item 1.  Legal Proceedings. ................................................  18

Item 1A. Risk Factors. .....................................................  18

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds. ......  18

Item 3.  Defaults Upon Senior Securities. ..................................  18

Item 4.  Submission of Matters to a Vote of Security Holders. ..............  18

Item 5.  Other Information. ................................................  18

Item 6.  Exhibits. .........................................................  18

                                        2
<PAGE>

           CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Certain statements in this report contain or may contain forward-looking
statements. These statements, identified by words such as "plan", "anticipate",
"believe", "estimate", "should," "expect" and similar expressions include our
expectations and objectives regarding our future financial position, operating
results and business strategy. These statements are subject to known and unknown
risks, uncertainties and other factors which may cause actual results,
performance or achievements to be materially different from any future results,
performance or achievements expressed or implied by such forward - looking
statements. These forward-looking statements were based on various factors and
were derived utilizing numerous assumptions and other factors that could cause
our actual results to differ materially from those in the forward-looking
statements. These factors include, but are not limited to, our ability to secure
suitable financing to continue with our existing business or change our business
and conclude a merger, acquisition or combination with a business prospect,
economic, political and market conditions and fluctuations, government and
industry regulation, interest rate risk, U.S. and global competition, and other
factors. Most of these factors are difficult to predict accurately and are
generally beyond our control. You should consider the areas of risk described in
connection with any forward-looking statements that may be made herein. Readers
are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date of this report. Readers should carefully review
this report in its entirety, including but not limited to our financial
statements and the notes thereto and the risks described in our Annual Report on
Form 10-K for the fiscal year ended May 31, 2008. We advise you to carefully
review the reports and documents we file from time to time with the Securities
and Exchange Commission (the "SEC"), particularly our quarterly reports on Form
10-Q and our current reports on Form 8-K. Except for our ongoing obligations to
disclose material information under the Federal securities laws, we undertake no
obligation to release publicly any revisions to any forward-looking statements,
to report events or to report the occurrence of unanticipated events.

                           OTHER PERTINENT INFORMATION

When used in this report, the terms "Premier," "we," the "Company," "our," and
"us" refers to Premier Energy Corp., a Florida corporation formerly known as
Premier Nursing Products Corp.

                                        3
<PAGE>

                         PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

                              PREMIER ENERGY CORP.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)
                                 Balance Sheets

                                     ASSETS
                                     ------

                                                          AS OF          AS OF
                                                       NOVEMBER 30,     MAY 31,
                                                           2008          2008
                                                                       (AUDITED)
                                                       ------------    --------

CURRENT ASSETS
  Cash and cash equivalents ........................     $    554      $ 23,907
                                                         --------      --------
    Total current assets ...........................          554        23,907

                                                         --------      --------
TOTAL ASSETS .......................................     $    554      $ 23,907
                                                         ========      ========

                LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)
                -------------------------------------------------

CURRENT LIABILITIES
  Accounts payable and accrued expenses ............     $  4,167      $      -
  Advances from related party ......................       11,101             -
                                                         --------      --------
    Total liabilities ..............................       15,268             -
                                                         --------      --------

STOCKHOLDERS' EQUITY (DEFICIENCY)
  Capital Stock (Note 3)
    Authorized:
      10,000,000 preferred shares, $0.0001 par value
    Issued and outstanding shares 0 ................            -             -
      250,000,000 common shares, $0.0001 par value
    Issued and outstanding shares:
      210,600,000 and 210,600,000 respectively .....       21,060        21,600
    Additional paid-in capital .....................       14,940        14,400
    Deficit accumulated during the development stage      (50,714)      (12,093)
                                                         --------      --------
  Total Stockholders Equity (Deficiency) ...........      (14,714)       23,907
                                                         --------      --------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY .........     $    554      $ 23,907
                                                         ========      ========

              The accompanying notes are an integral part of these
                          interim financial statements.

                                        4
<PAGE>
<TABLE>
                                                     PREMIER ENERGY CORP.
                                              fka Premier Nursing Products Corp.
                                                 (A Development Stage Company)
                                                   Statements of Operations
<CAPTION>
                                                                                                           CUMULATIVE RESULTS
                                       THREE MONTHS     THREE MONTHS      SIX MONTHS       SIX MONTHS      OF OPERATIONS FROM
                                          ENDED            ENDED            ENDED            ENDED          DECEMBER 26, 2006
                                       NOVEMBER 30,     NOVEMBER 30,     NOVEMBER 30,     NOVEMBER 30,    (DATE OF INCEPTION)
                                           2008             2007             2008             2007        TO NOVEMBER 30, 2008
                                      -------------    -------------    -------------    -------------    --------------------
<S>                                   <C>              <C>              <C>              <C>              <C>
REVENUES

EXPENSES
  State of Florida Filing Costs ...   $           -    $           -    $           -    $           -        $         335
  Professional Fees ...............          28,954                -           29,184            3,633               35,638
  Salary expense ..................           4,167                -            4,167                -                4,167
  General and administrative ......           5,313            3,003            5,370            3,003               10,485
  Other Expense / (Income) ........            (101)             164             (100)             189                   89
                                      -------------    -------------    -------------    -------------        -------------

LOSS BEFORE TAXES .................   $     (38,333)   $      (3,167)   $     (38,621)   $      (6,825)       $     (50,714)
                                      -------------    -------------    -------------    -------------        -------------

PROVISION FOR INCOME TAXES ........               -                -                -                -                    -
                                      -------------    -------------    -------------    -------------        -------------

PER SHARE DATA:

  Basic and diliuted loss per share   $       (0.00)   $       (0.00)   $       (0.00)   $       (0.00)
                                      =============    =============    =============    =============

  Common shares outstanding .......     210,600,000      162,000,000      210,600,000      162,000,000
                                      =============    =============    =============    =============

                      The accompanying notes are an integral part of these interim financial statements.

                                                               5
</TABLE>
<PAGE>
<TABLE>
                                           PREMIER ENERGY CORP.
                                    fka Premier Nursing Products Corp.
                                       (A Development Stage Company)
                              Statements of Stockholders' Equity (Deficiency)
<CAPTION>
                                                                                 Deficit
                                                                               Accumulated
                                                                Additional       during
                                      Common                      Paid-In      Development
                                      Shares         Amount       Capital         Stage          Total
                                    -----------   -----------   -----------    -----------    -----------
<S>                                 <C>           <C>           <C>            <C>            <C>
Inception - December 26, 2006 ...             -   $         -   $         -    $         -    $         -

Common shares issued for cash
  at $0.0001 per share to founder
  on December 27, 2006 ..........   162,000,000        16,200        (7,200)             -          9,000

Loss for the year ending
  May 31, 2007 ..................             -             -             -           (150)          (150)
                                    -----------   -----------   -----------    -----------    -----------


Balance - May 31, 2007 Audited ..   162,000,000        16,200        (7,200)          (150)         8,850
                                    ===========   ===========   ===========    ===========    ===========

Common Shares issued for cash
  at $0.0006 (par value $0.001)
  on October 30, 2007 ...........    48,600,000         4,860        22,140              -         27,000

Loss for the Year ending
  May 31, 2008 ..................             -             -             -        (11,943)       (11,943)
                                    -----------   -----------   -----------    -----------    -----------

Balance - May 31, 2008 Audited ..   210,600,000        21,060        14,940        (12,093)        23,907
                                    ===========   ===========   ===========    ===========    ===========

Loss for the six months ended
  November 30, 2008 .............             -             -             -        (38,621)       (38,621)
                                    -----------   -----------   -----------    -----------    -----------

Balance - November 30, 2008 .....   210,600,000   $    21,060   $    14,940    $   (50,714)   $   (14,714)
                                    ===========   ===========   ===========    ===========    ===========

            The accompanying notes are an integral part of these interim financial statements.

                                                     6
</TABLE>
<PAGE>
<TABLE>
                                         PREMIER ENERGY CORP.
                                  fka Premier Nursing Products Corp.
                                     (A Development Stage Company)
                                       Statements of Cash Flows
<CAPTION>
                                                                                   CUMULATIVE RESULTS
                                                     SIX MONTHS     SIX MONTHS     OF OPERATIONS FROM
                                                        ENDED          ENDED        DECEMBER 26, 2006
                                                    NOVEMBER 30,   NOVEMBER 30,    (DATE OF INCEPTION)
                                                        2008           2007       TO NOVEMBER 30, 2008
                                                    ------------   ------------   --------------------
<S>                                                   <C>            <C>          <C>
OPERATING ACTIVITIES
  Loss for the period ..........................      $(38,621)      $ (6,825)           $(50,714)

  Changes in Operating Assets and Liabilities:
  Increase (decrease) in accounts payable and
    accrued liabilities ........................         4,167              -               4,167
                                                      --------       --------            --------
  Net cash used in operating activities ........       (34,454)        (6,825)            (46,547)
                                                      --------       --------            --------


FINANCING ACTIVITIES
  Advance from related party ...................        11,101              -              11,101
  Common stock issued for cash .................             -         27,000              36,000
                                                      --------       --------            --------
  Net cash provided by financing activities ....        11,101         27,000              47,101
                                                      --------       --------            --------


INCREASE IN CASH AND CASH EQUIVALENTS ..........       (23,353)        20,175                 554

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD        23,907          8,850                   -
                                                      --------       --------            --------

CASH AND CASH EQUIVALENTS AT END OF PERIOD .....      $    554       $ 29,025            $    554
                                                      ========       ========            ========


Supplemental Cash Flow Disclosures:

  Cash paid for:
    Interest expense ...........................      $      -       $      -            $      -
                                                      ========       ========            ========
    Income taxes ...............................      $      -       $      -            $      -
                                                      ========       ========            ========

          The accompanying notes are an integral part of these interim financial statements.

                                                   7
</TABLE>
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

   (A) BASIS OF PRESENTATION

   The accompanying financial statements have been prepared by the Company
   without audit. In the opinion of management, all adjustments (which include
   only normal recurring adjustments) necessary to present fairly the financial
   position, results of operations, and cash flows at November 30, 2008 and for
   all periods presented herein, have been made.

   Certain information and footnote disclosures normally included in financial
   statements prepared in accordance with accounting principles generally
   accepted in the United States of America have been condensed or omitted. It
   is suggested that these condensed financial statements be read in conjunction
   with the financial statements and notes thereto included in the Company's May
   31, 2008 audited financial statements. The results of operations for the
   periods ended November 30, 2008 and 2007 are not necessarily indicative of
   the operating results for the full years.

   (B) ORGANIZATION

   Premier Energy Corp. fka Premier Nursing Products, Corp. (a development stage
   company) (the "Company") was incorporated under the laws of the State of
   Florida on December 26, 2006. On September 25, 2008 the Board of Directors
   and holder of a majority of our issued and outstanding common stock adopted a
   resolution changing the name of Premier Nursing Products Corp. to Premier
   Energy Corp. and in connection therewith on September 25, 2008 we filed
   Articles of Amendment to our Articles of Incorporation with the Secretary of
   State of Florida. The effective time of the name change will be close of
   business on October 6, 2008. There will be no mandatory exchange of stock
   certificates. Following the name change, the share certificates which reflect
   our prior name will continue to be valid. Certificates reflecting the
   corporate new name will be issued in due course as old share certificates are
   tendered for exchange or transfer to our transfer agent Activities during the
   development stage include developing the business plan and raising capital.

   (C) USE OF ESTIMATES

   In preparing financial statements in conformity with generally accepted
   accounting principles, management is required to make estimates and
   assumptions that affect the reported amounts of assets and liabilities and
   the disclosure of contingent assets and liabilities at the date of the
   financial statements and revenues and expenses during the reported period.
   Actual results could differ from those estimates.

   (D) CASH AND CASH EQUIVALENTS

   For purposes of the cash flow statements, the Company considers all highly
   liquid investments with original maturities of three months or less at the
   time of purchase to be cash equivalents. The Company at times has cash in
   excess of FDIC insurance limits and places its temporary cash investments
   with high credit quality financial institutions. At November 30, 2008, the
   Company did not have any balances that exceeded FDIC insurance limits.

                                        8
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

   (E) RECLASSIFICATIONS

   Certain amounts from prior periods have been reclassified to conform to the
   current period presentation

   (F) STOCK-BASED COMPENSATION

   Effective January 1, 2006 The Company adopted SFAS No. 123R "Share-Based
   Payment" ("SFAS 123R"), a revision to SFAS No. 123 "Accounting for
   Stock-Based Compensation" ("SFAS 123"). Prior to the adoption of SFAS 123R
   the Company accounted for stock options in accordance with APB Opinion No. 25
   "Accounting for Stock Issued to Employees" (the intrinsic value method), and
   accordingly, recognized no compensation expense for stock option grants.

   Under the modified prospective approach, the provisions of SFAS 123R apply to
   new awards and to awards that were outstanding on January 1, 2006 that are
   subsequently modified, repurchased or cancelled. Under the modified
   prospective approach, compensation cost recognized in the year ended December
   31, 2006 includes compensation cost for all share-based payments granted
   prior to, but not yet vested as of January 1, 2006, based on the grant -date
   fair value estimated in accordance with the original provisions of SFAS 123,
   and the compensation costs for all share-based payments granted subsequent to
   January 31, 2006, based on the grant-date fair value estimated in accordance
   with the provisions of SFAS 123R. Prior periods were not restated to reflect
   the impact of adopting the new standard.

   (G) LOSS PER SHARE

   Basic and diluted net loss per common share is computed based upon the
   weighted average common shares outstanding as defined by Financial Accounting
   Standards No. 128, "Earnings Per Share." As of November 30, 2008 and 2007,
   there we no common share equivalents outstanding.

   (H) BUSINESS SEGMENTS

   The Company operates in one segment and therefore segment information is not
   presented.

   (I) LONG-LIVED ASSETS

   The Company accounts for long-lived assets under the Statements of Financial
   Accounting Standards Nos. 142 and 144 "Accounting for Goodwill and Other
   Intangible Assets" and "Accounting for Impairment or Disposal of Long-Lived
   Assets" ("SFAS No. 142 and 144"). In accordance with SFAS No. 142 and 144,
   long-lived assets, goodwill and certain identifiable intangible assets held
   and used by the Company are reviewed for impairment whenever events or
   changes in circumstances indicate that the carrying amount of an asset may
   not be recoverable. For purposes of evaluating the recoverability of
   long-lived assets, goodwill and intangible assets, the recoverability test is
   performed using undiscounted net cash flows related to the long-lived assets.

                                        9
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

   (J) RECENT ACCOUNTING PRONOUNCEMENTS

   In June 2008, the FASB issued FASB Staff Position EITF 03-6-1, Determining
   Whether Instruments Granted in Share-Based Payment Transactions Are
   Participating Securities, ("FSP EITF 03-6-1"). FSP EITF 03-6-1 addresses
   whether instruments granted in share-based payment transactions are
   participating securities prior to vesting, and therefore need to be included
   in the computation of earnings per share under the two-class method as
   described in FASB Statement of Financial Accounting Standards No. 128,
   "Earnings per Share." FSP EITF 03-6-1 is effective for financial statements
   issued for fiscal years beginning on or after December 15, 2008 and earlier
   adoption is prohibited. We are not required to adopt FSP EITF 03-6-1; neither
   do we believe that FSP EITF 03-6-1 would have material effect on our
   consolidated financial position and results of operations if adopted.

   In May 2008, the Financial Accounting Standards Board ("FASB") issued SFAS
   No. 163, "Accounting for Financial Guarantee Insurance Contracts-and
   interpretation of FASB Statement No. 60". SFAS No. 163 clarifies how
   Statement 60 applies to financial guarantee insurance contracts, including
   the recognition and measurement of premium revenue and claims liabilities.
   This statement also requires expanded disclosures about financial guarantee
   insurance contracts. SFAS No. 163 is effective for fiscal years beginning on
   or after December 15, 2008, and interim periods within those years. SFAS No.
   163 has no effect on the Company's financial position, statements of
   operations, or cash flows at this time.

   In May 2008, the Financial Accounting Standards Board ("FASB") issued SFAS
   No. 162, "The Hierarchy of Generally Accepted Accounting Principles". SFAS
   No. 162 sets forth the level of authority to a given accounting pronouncement
   or document by category. Where there might be conflicting guidance between
   two categories, the more authoritative category will prevail. SFAS No. 162
   will become effective 60 days after the SEC approves the PCAOB's amendments
   to AU Section 411 of the AICPA Professional Standards. SFAS No. 162 has no
   effect on the Company's financial position, statements of operations, or cash
   flows at this time.

   In March 2008, the Financial Accounting Standards Board, or FASB, issued SFAS
   No. 161, Disclosures about Derivative Instruments and Hedging Activities--an
   amendment of FASB Statement No. 133. This standard requires companies to
   provide enhanced disclosures about (a) how and why an entity uses derivative
   instruments, (b) how derivative instruments and related hedged items are
   accounted for under Statement 133 and its related interpretations, and (c)
   how derivative instruments and related hedged items affect an entity's
   financial position, financial performance, and cash flows. This Statement is
   effective for financial statements issued for fiscal years and interim
   periods beginning after November 15, 2008, with early application encouraged.
   The Company has not yet adopted the provisions of SFAS No. 161, but does not
   expect it to have a material impact on its consolidated financial position,
   results of operations or cash flows.

                                       10
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

   In December 2007, the SEC issued Staff Accounting Bulletin (SAB) No. 110
   regarding the use of a "simplified" method, as discussed in SAB No. 107 (SAB
   107), in developing an estimate of expected term of "plain vanilla" share
   options in accordance with SFAS No. 123 (R), Share-Based Payment. In
   particular, the staff indicated in SAB 107 that it will accept a company's
   election to use the simplified method, regardless of whether the company has
   sufficient information to make more refined estimates of expected term. At
   the time SAB 107 was issued, the staff believed that more detailed external
   information about employee exercise behavior (e.g., employee exercise
   patterns by industry and/or other categories of companies) would, over time,
   become readily available to companies. Therefore, the staff stated in SAB 107
   that it would not expect a company to use the simplified method for share
   option grants after December 31, 2007. The staff understands that such
   detailed information about employee exercise behavior may not be widely
   available by December 31, 2007. Accordingly, the staff will continue to
   accept, under certain circumstances, the use of the simplified method beyond
   December 31, 2007. The Company currently uses the simplified method for
   "plain vanilla" share options and warrants, and will assess the impact of SAB
   110 for fiscal year 2009. It is not believed that this will have an impact on
   the Company's consolidated financial position, results of operations or cash
   flows.

   In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in
   Consolidated Financial Statements--an amendment of ARB No. 51. This statement
   amends ARB 51 to establish accounting and reporting standards for the
   noncontrolling interest in a subsidiary and for the deconsolidation of a
   subsidiary. It clarifies that a noncontrolling interest in a subsidiary is an
   ownership interest in the consolidated entity that should be reported as
   equity in the consolidated financial statements. Before this statement was
   issued, limited guidance existed for reporting noncontrolling interests. As a
   result, considerable diversity in practice existed. So-called minority
   interests were reported in the consolidated statement of financial position
   as liabilities or in the mezzanine section between liabilities and equity.
   This statement improves comparability by eliminating that diversity. This
   statement is effective for fiscal years, and interim periods within those
   fiscal years, beginning on or after December 15, 2008 (that is, January 1,
   2009, for entities with calendar year-ends). Earlier adoption is prohibited.
   The effective date of this statement is the same as that of the related
   Statement 141 (revised 2007). The Company will adopt this Statement beginning
   March 1, 2009. It is not believed that this will have an impact on the
   Company's consolidated financial position, results of operations or cash
   flows.

   In December 2007, the FASB, issued FAS No. 141 (revised 2007), Business
   Combinations'. This Statement replaces FASB Statement No. 141, Business
   Combinations, but retains the fundamental requirements in Statement 141. This
   Statement establishes principles and requirements for how the acquirer: (a)
   recognizes and measures in its financial statements the identifiable assets
   acquired, the liabilities assumed, and any noncontrolling interest in the
   acquiree; (b) recognizes and measures the goodwill acquired in the business
   combination or a gain from a bargain purchase; and (c) determines what

                                       11
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

   information to disclose to enable users of the financial statements to
   evaluate the nature and financial effects of the business combination. This
   statement applies prospectively to business combinations for which the
   acquisition date is on or after the beginning of the first annual reporting
   period beginning on or after December 15, 2008. An entity may not apply it
   before that date. The effective date of this statement is the same as that of
   the related FASB Statement No. 160, Noncontrolling Interests in Consolidated
   Financial Statements. The Company will adopt this statement beginning March
   1, 2009. It is not believed that this will have an impact on the Company's
   consolidated financial position, results of operations or cash flows.

   In February 2007, the FASB, issued SFAS No. 159, The Fair Value Option for
   Financial Assets and Liabilities--Including an Amendment of FASB Statement
   No. 115. This standard permits an entity to choose to measure many financial
   instruments and certain other items at fair value. This option is available
   to all entities. Most of the provisions in FAS 159 are elective; however, an
   amendment to FAS 115 Accounting for Certain Investments in Debt and Equity
   Securities applies to all entities with available for sale or trading
   securities. Some requirements apply differently to entities that do not
   report net income. SFAS No. 159 is effective as of the beginning of an
   entity's first fiscal year that begins after November 15, 2007. Early
   adoption is permitted as of the beginning of the previous fiscal year
   provided that the entity makes that choice in the first 120 days of that
   fiscal year and also elects to apply the provisions of SFAS No. 157 Fair
   Value Measurements. The Company will adopt SFAS No. 159 beginning March 1,
   2008 and is currently evaluating the potential impact the adoption of this
   pronouncement will have on its consolidated financial statements.

   In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements This
   statement defines fair value, establishes a framework for measuring fair
   value in generally accepted accounting principles (GAAP), and expands
   disclosures about fair value measurements. This statement applies under other
   accounting pronouncements that require or permit fair value measurements, the
   Board having previously concluded in those accounting pronouncements that
   fair value is the relevant measurement attribute. Accordingly, this statement
   does not require any new fair value measurements. However, for some entities,
   the application of this statement will change current practice. This
   statement is effective for financial statements issued for fiscal years
   beginning after November 15, 2007, and interim periods within those fiscal
   years. Earlier application is encouraged, provided that the reporting entity
   has not yet issued financial statements for that fiscal year, including
   financial statements for an interim period within that fiscal year. The
   Company will adopt this statement March 1, 2008, and it is not believed that
   this will have an impact on the Company's consolidated financial position,
   results of operations or cash flows.

   (K) FAIR VALUE OF FINANCIAL INSTRUMENTS.

   The carrying amounts reported in the balance sheet for cash, accounts
   payable, accrued expenses and notes payable approximate fair value based on
   the short-term maturity of these instruments.

                                       12
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

   (L) INCOME TAXES

   The Company accounts for income taxes under the Statement of Financial
   Accounting Standards No. 109, "Accounting for Income Taxes" ("Statement
   109"). Under Statement 109, deferred tax assets and liabilities are
   recognized for the future tax consequences attributable to differences
   between the financial statements carrying amounts of existing assets and
   liabilities and their respective tax bases. Deferred tax assets and
   liabilities are measured using enacted tax rates expected to apply to taxable
   income in the years in which those temporary differences are expected to be
   recovered or settled. Under Statement 109, the effect on deferred tax assets
   and liabilities of a change in tax rates is recognized in income in the
   period that includes the enactment date.

NOTE 2 ADVANCES

   A related party has advanced the Company funds to pay bills. The amounts are
   non interest bearing and payable upon demand.

NOTE 3 STOCKHOLDERS' EQUITY

   On May 30, 2008, the Company increased its number of Authorized Common Shares
   from 100,000,000 (One Hundred Million Common Shares) to 250,000,000 (Two
   Hundred and Fifty Million Common Shares) and the Par Value changed from
   ($.001) to ($.0001). The Aggregate par value of the Common Shares changed
   from ($10,000) TO ($25,000) and the Aggregate par value of the Preferred
   changed from ($10,000) TO ($1,000). The number of authorized preferred shares
   remained at 10,000,000.

   On July 28, 2008 the Corporation's Board of Directors and the holder of a
   majority of its issued and outstanding common stock adopted resolutions
   approving an eighteen for one (18:1) forward stock split of the Corporation's
   issued and outstanding common stock, par value $0.0001 per share. The split
   became effective August 8, 2008. All prior amounts have been adjusted
   retroactive for the stock split.

   On September 5, 2008, the Company and its principal shareholder and executive
   officer, Sheldon R. Rose, entered into an agreement with ZRV Consulting Inc.
   pursuant to which ZRV acquired 162,000,000 shares of Premier for a cash
   consideration of $300,000. . The transaction was completed on September 5,
   2008. As a result of the transaction, there are currently outstanding
   210,600,000 common shares of which ZRV owns 162,000,000 common shares or
   approximately 77% of the outstanding common shares.

NOTE 4 COMMITMENTS AND CONTINGENCIES

   EMPLOYMENT AGREEMENT

   On October 16, 2008 The Company entered into an employment agreement with Dr.
   Prodanovic. Under the terms of the 24 month agreement, he will serve as Chief
   Executive Officer. In addition, during the term of the agreement we agreed to
   cause him to be successively nominated for election to the Board of
   Directors. As compensation, the Company agreed to pay Dr. Prodanovic an
   annual base salary of $100,000, which such base is subject to annual merit
   review and increase as deemed appropriate by the Board, together with bonus

                                       13
<PAGE>

                              Premier Energy Corp.
                       fka Premier Nursing Products Corp.
                          (A Development Stage Company)

                          NOTES TO FINANCIAL STATEMENTS
                                November 30, 2008

   compensation in amounts as may be determined by the Board. The Company has
   agreed to issue Dr. Prodanovic options to purchase 200,000 of our common
   stock. As of November 30, 2008 the Options have not be granted and the
   Company is currently negotiating the terms. He is also entitled to
   participate in such benefit packages as we provide to similarly situated
   employees, four weeks paid vacation and 10 paid holidays. The agreement
   contains customary provisions related to non-compete, confidentiality,
   non-solicitation and invention assignment. As of November 30, 2008 the
   Company recorded accrued salary of $4,167.

   The agreement may be terminated by us for cause as set forth in the
   agreement, by us without cause, or by Dr. Prodanovic under certain
   circumstances. If we terminate the agreement for cause, he is not entitled to
   any severance benefits. If we should terminate the agreement without cause,
   we are obligated to pay Dr. Prodanovic an amount equal to his monthly base
   salary for the greater of 24 months or until he is hired in a new position
   which is consistent with his experience and stature. If such new position
   pays less than his then current base salary we are obligated to pay the
   difference for the balance of the 24 month severance period. If his
   employment in the new position should terminate prior to the expiration of
   the 24 month severance period, we are obligated to pay his monthly base
   salary during the remaining period. In the event we should fail to appoint
   Dr. Prodanovic Chief Executive Officer and a member of our Board of Directors
   in any successive periods during the term of the agreement, should we fail to
   compensate him pursuant to the terms of the agreement, or if there is a
   material breach of the agreement, Dr. Prodanovic is entitled to terminate the
   agreement and we shall be obligated to pay him the same severance benefits
   had we terminated the agreement without cause.

NOTE 5 GOING CONCERN

   The Company's financial statements are prepared using generally accepted
   accounting principles in the United States of America applicable to a going
   concern which contemplates the realization of assets and liquidation of
   liabilities in the normal course of business. The Company has not yet
   established an ongoing source of revenues sufficient to cover its operating
   costs and allow it to continue as a going concern. The ability of the Company
   to continue as a going concern is dependent on the Company obtaining adequate
   capital to fund operating losses until it becomes profitable. If the Company
   is unable to obtain adequate capital, it could be forced to cease operations.

   In order to continue as a going concern, the Company will need, among other
   things, additional capital resources. Management's plan is to obtain such
   resources for the Company by obtaining capital from management and
   significant shareholders sufficient to meet its minimal operating expenses
   and seeking equity and/or debt financing. However management cannot provide
   any assurances that the Company will be successful in accomplishing any of
   its plans.

   The ability of the Company to continue as a going concern is dependent upon
   its ability to successfully accomplish the plans described in the preceding
   paragraph and eventually secure other sources of financing and attain
   profitable operations. The accompanying financial statements do not include
   any adjustments that might be necessary if the Company is unable to continue
   as a going concern.

                                       14
<PAGE>

ITEM 2.  MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATION

Overview

We are a development stage company, incorporated in the State of Florida on
December 26, 2006, to establish itself as a manufacturing, wholesale marketing
and sales company specializing in breastfeeding nursing products. We initially
intended to develop the market and sell through retail distribution channels
(mass merchant retail chains, mass merchant retail food and drug chains,
independent retailers and e-commerce retailers) breastfeeding nursing products
throughout the United States.

During the earlier part of fiscal 2008 we made a decision to discontinue our
previous activities and focus our efforts in a new area concentrating on oil and
gas exploration and production. One of the first steps in this new direction
included the October 16, 2008 hiring of Dr. Anton Prodanovic as our Chief
Executive Officer. We entered into a 24 month employment agreement with Dr.
Prodanovic pursuant to which we agreed to pay him an annual base salary of
$100,000, which such base is subject to annual merit review and increase as
deemed appropriate by the Board, together with bonus compensation in amounts as
may be determined by the Board. We have agreed to grant Dr. Prodanovic options
to purchase 200,000 of our common stock at an exercise price equal to fair
market value on the date of grant. These options have not yet been granted.

Our efforts will now be focused on the conduct of oil and gas exploration and
production activities. We are seeking to create value through a balance of
drilling activities, exploration and acquisitions of assets and companies. We
will seek to locate and develop natural oil and gas reserves and extract these
reserves while maintaining economical production and administrative costs.

In October 2008 we announced that we had initiated the process to acquire a
major property in Texas with substantial oil and gas production and reserves as
well as other operating business interests. The property is in excess of 400,000
contiguous acres encompassing a number of Texas counties. No financial agreement
has been reached to date and none is contemplated at this time.

Results of Operations
---------------------

We did not generate any revenue during the three months and six months ended
November 30, 2008.

Total expenses for the three months ending November 30, 2008 and 2007
represented fees for general and administrative and professional fees and the
costs associated with stock transfer expense and Edgarizing expense. Total
expenses for the three months ended November 30, 2008 were $38,621 of which
$29,184 represented professional fees. In addition, we accrued a salary expense
(please see the attached employment agreement). This compares to total expenses
for the three months ended November 30, 2007 of $3,167. The fees during the
three months ended November 30, 2007 associated with a registration statement we
filed with the Securities and Exchange Commission.

Liquidity and Capital Resources
-------------------------------

At November 30, 2008 we had an accumulated deficit of $50,714 as compared to an
accumulated deficit of $12,093 at May 31, 2008. During the three months ended
November 30, 2008 ZRV Consulting, a related party, advanced us $11,101 for
working capital

We do not have sufficient funds to pay our operating expenses.

                                       15
<PAGE>

Cash Flows

Net cash used in operating activities for the six months ended November 30, 2008
was $34,454 as compared to $6,825 for the six months ended November 30, 2007.
These amounts represented our net losses for the respective periods.

Net cash provided by financing activities for the six months ended November 30,
2008 was $11,101 as compared to $0 for the comparable period in fiscal 2008 and
represents working capital advances to us from a related party.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable to a smaller reporting company.

ITEM 4T. CONTROLS AND PROCEDURES

        Management's Report On Internal Control Over Financial Reporting
        ----------------------------------------------------------------

Our management is responsible for establishing and maintaining adequate internal
control over financial reporting. Internal control over financial reporting is
defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange
Act of 1934 as a process designed by, or under the supervision of, the company's
principal executive and principal financial officers and effected by the
company's board of directors, management and other personnel, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
accounting principles generally accepted in the United States of America and
includes those policies and procedures that:

   -  Pertain to the maintenance of records that in reasonable detail accurately
      and fairly reflect the transactions and dispositions of the assets of the
      company;

   -  Provide reasonable assurance that transactions are recorded as necessary
      to permit preparation of financial statements in accordance with
      accounting principles generally accepted in the United States of America
      and that receipts and expenditures of the company are being made only in
      accordance with authorizations of management and directors of the company;
      and

   -  Provide reasonable assurance regarding prevention or timely detection of
      unauthorized acquisition, use or disposition of the company's assets that
      could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate. All internal control systems,
no matter how well designed, have inherent limitations. Therefore, even those
systems determined to be effective can provide only reasonable assurance with
respect to financial statement preparation and presentation. Because of the
inherent limitations of internal control, there is a risk that material
misstatements may not be prevented or detected on a timely basis by internal
control over financial reporting. However, these inherent limitations are known
features of the financial reporting process. Therefore, it is possible to design
into the process safeguards to reduce, though not eliminate, this risk.

                                       16
<PAGE>

As of November 30, 2008 management assessed the effectiveness of our internal
control over financial reporting based on the criteria for effective internal
control over financial reporting established in Internal Control--Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission ("COSO") and SEC guidance on conducting such assessments. Based on
that evaluation, they concluded that, during the period covered by this report,
such internal controls and procedures were not effective to detect the
inappropriate application of US GAAP rules as more fully described below. This
was due to deficiencies that existed in the design or operation of our internal
controls over financial reporting that adversely affected our internal controls
and that may be considered to be material weaknesses.

The matters involving internal controls and procedures that our management
considered to be material weaknesses under the standards of the Public Company
Accounting Oversight Board were: (1) lack of a functioning audit committee due
to a lack of a majority of independent members and a lack of a majority of
outside directors on our board of directors, resulting in ineffective oversight
in the establishment and monitoring of required internal controls and
procedures; (2) inadequate segregation of duties consistent with control
objectives; and (3) ineffective controls over period end financial disclosure
and reporting processes. The aforementioned material weaknesses were identified
by our Chief Executive Officer in connection with the review of our financial
statements as of November 30, 2008.

Management believes that the material weaknesses set forth in items (2) and (3)
above did not have an effect on our financial results. However, management
believes that the lack of a functioning audit committee and the lack of a
majority of outside directors on our board of directors results in ineffective
oversight in the establishment and monitoring of required internal controls and
procedures, which could result in a material misstatement in our financial
statements in future periods.

Management's Remediation Initiatives
------------------------------------

In an effort to remediate the identified material weaknesses and other
deficiencies and enhance our internal controls, we have initiated, or plan to
initiate, the following series of measures:

We will create a position to segregate duties consistent with control objectives
and will increase our personnel resources and technical accounting expertise
within the accounting function when funds are available to us. And, we plan to
appoint one or more outside directors to our board of directors who shall be
appointed to an audit committee resulting in a fully functioning audit committee
who will undertake the oversight in the establishment and monitoring of required
internal controls and procedures such as reviewing and approving estimates and
assumptions made by management when funds are available to us.

Management believes that the appointment of one or more outside directors, who
shall be appointed to a fully functioning audit committee, will remedy the lack
of a functioning audit committee and a lack of a majority of outside directors
on our Board.

We anticipate that these initiatives will be at least partially, if not fully,
implemented by July 31, 2009. Additionally, we plan to test our updated controls
and remediate our deficiencies by July 31, 2009.

                                       17
<PAGE>

Changes in internal controls over financial reporting
-----------------------------------------------------

There was no change in our internal controls over financial reporting that
occurred during the period covered by this report, which has materially
affected, or is reasonably likely to materially affect, our internal controls
over financial reporting.

                           PART II. OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

Not applicable to a smaller reporting company.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

ITEM 5.  OTHER INFORMATION.

None.

ITEM 6.  EXHIBITS.

10.1     Employment Agreement dated October 16, 2008 by and between Premier
         Energy Corp. and Dr. Anton Prodanovic

31.1     Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive
         Officer

31.2     Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial and
         Accounting Officer

32.1     Section 1350 Certification of Principal Executive Officer and Principal
         Financial and Accounting Officer

                                       18
<PAGE>

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                    Premier Energy Corp.
                    fka Premier Nursing Products Corp.


                    By: /s/ Michael Yuster
                        ------------------
                    Michael Yuster
                    President, Secretary, Treasurer, and Director
                    Principal Executive Officer and Principal Financial and
                    Accounting Officer


                    Dated: January 15, 2009

                                       19